Aveo's Tivozanib kidney cancer drug will get the nod from regulators.
A cautionary sign for today’s frothy market
Beware market sages offering investment advice.
Want superior returns? Get out of your comfort zone
When it comes to investing, the right temperament is crucial.
We like Aveo Pharmaceuticals and Bank of America in 2013
After taking a beating, Bank of America's stock has staged an impressive comeback.
Two 2013 picks: Bank of America and Aveo Pharmaceuticals
Bank of American could be a break-out financial play next year.
Beware the Ben Bernanke put
This market reliance on the Federal Reserve Bank chairman’s belief system makes us nervous.
When it comes to investing, survival is job one
Danger always lies where there is a crowd. Today the crowd thinks safety is safe.
How Aveo's Tivo cancer drug stacks up against rivals
Across the board the relative safety profile of Tivo stands out.
Test your risk intelligence - and become a smarter investor
You will sometimes be wrong even when you are right - and sometimes you will just be wrong.
Holding tight to Argentina’s YPF
Manager Chris Rees says he is holding tight to Argentina's YPF
Chris Rees
Chris Rees
Tenstocks was created by Chris Rees, a private investor. He has been featured in Forbes, Dow Jones Marketwatch, Britain’s The Times and Sunday Express and Canada’s Globe and Mail. He is also profiled in the book ‘The Warren Buffetts Next Door’ by Matthew Schifrin.
